chartexchange

PRME
Prime Medicine, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:59:56 PM EST
3.76USD-1.702%(-0.06)2,522,905
Pre-marketNov 19, 2026 9:28:30 AM EST
3.86USD+1.047%(+0.04)
3.7500Bid3.7600Ask0.0100Spread
Loading…
Loading…
838.45M
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$3.82
Beta
2.46
52-Week High
$5.91 2026-10-29
52-Week Low
$2.67 2026-06-11
SMA 50
$3.72
SMA 200
$3.51
Avg. Vol 10D
5.77M
Avg. Vol 30D
5.71M
Avg. Vol 90D
4.06M
Relative Vol
0.44
222.99M
59.60M
29,147,049
0.3200%
6,800,000
8,490
Dec 18, 2018 · $0.213
PRME Profile

The investment seeks to provide long-term total return. Under normal market conditions, the fund will seek to achieve its investment objective by investing at least 80% of its net assets (including investment borrowings) in U.S. and non-U.S. exchange-traded real estate securities, which includes real estate investment trusts ("REITs"), real estate operating companies ("REOCs") and common stocks or depositary receipts of companies primarily engaged in the real estate industry (collectively, "Real Estate Securities"). It is non-diversified.

PRME Performance
PeriodPriceDateChangeBeta
1W3.892026-11-12-3.34%4.644
1M3.832026-10-19-1.83%2.939
3M3.542026-08-19+6.21%3.365
6M2.702026-05-19+39.26%2.645
1Y3.722025-11-19+1.07%2.457
2Y3.172024-11-19+18.61%—
5Y15.762022-10-21-76.14%1.994
PRME Stock Summary

Prime Medicine, Inc. Common Stock (NASDAQ:PRME) stock price today is $3.76, and today's volume is 2,501,469. PRME is down 1.571% today. The 30 day average volume is 5.71M. PRME market cap is $838.45M with 222.99M shares outstanding.